Structure and antigenicity of lipoarabinomannan from BCG Free

Abstract

Lipoarabinomannan (LAM), a major lipoglycan of the mycobacterial cell envelope, was previously recognized as existing in two major forms: LAM with arabinofuranosyl (Ara)-containing termini (AraLAM) and a mannose-capped version (ManLAM) in which the majority of these termini are modified by additional mannose residues. Since ManLAM was first recognized in the virulent (Erdman) strain of and the non-capped version in a rapidly growing, attenuated, H37Ra strain, it was thought that mannose capping may be a key factor in virulence. In the present study, LAM from BCG was isolated and the non-reducing termini sequenced through differential -alkylation, partial depolymerization and gas chromatography-mass spectrometric analyses of fragments. LAM from BCG contains a short mannan backbone, highly branched arabinofuranosyl-containing side chains and several mannosyl residues capping the non-reducing termini of these side chains. Thus, LAM from BCG is of the ManLAM type, showing no major structural differences at the non-reducing ends from the Erdman product. This observation led us to examine the earlier strain and to conclude that it showed little resemblance to conventional strains of Thus, the absence of mannose caps may be more a feature of rapid growth than of avirulence. These results demonstrate that the relationship between mannose capping and disease induction is not a simple one. However, use of a panel of LAM-specific monoclonal antibodies showed antigenic differences between the BCG and the Erdman products, suggesting the presence of features specific to the different strains and pointing to LAM as a molecule within which further species and strain variations reside.

Loading

Article metrics loading...

/content/journal/micro/10.1099/00221287-139-11-2649
1993-11-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/micro/139/11/mic-139-11-2649.html?itemId=/content/journal/micro/10.1099/00221287-139-11-2649&mimeType=html&fmt=ahah

References

  1. Barnes P. F., Fong S.-J., Brennan P. J., Twomey P. E., Mazumder A., Modlin R. L. 1990; Local production of tumor necrosis factor and INF-γ in tuberculous pleuritis. Journal of Immunology 145:149–154
    [Google Scholar]
  2. Barnes P. F., Chatterjee D., Brennan P. J., Rea T. H., Modlin R. L. 1992; Tumor necrosis factor production in patients with leprosy. Infection and Immunity 60:1441–1446
    [Google Scholar]
  3. Chan J., Fan X., Hunter S. W., Brennan P. J., Bloom B. R. 1991; Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infection and Immunity 59:1755–1761
    [Google Scholar]
  4. Chatterjee D., Bozic C. M., Mcneil M., Brennan P. J. 1991; Structural features of the arabinan component of the lipoarabinomannan of Mycobacterium tuberculosis. Journal of Biological Chemistry 266:9652–9660
    [Google Scholar]
  5. Chatterjee D., Hunter S. W., Mcneil M., Brennan P. J. 1992a; Lipoarabinomannan. Multiglycosylated form of the mycobacterial mannosylphosphatidylinositols. Journal of Biological Chemistry 267:6228–6233
    [Google Scholar]
  6. Chatterjee D., Lowell K., Rivoire B., Mcneil M., Brennan P. J. 1992b; Lipoarabinomannan of Mycobacterium tuberculosis,Capping with mannosyl residues in some strains. Journal of Biological Chemistry 267:6234–6239
    [Google Scholar]
  7. Chatterjee D., Roberts A. D., Lowell K., Brennan P. J., Orme I. 1992c; Structural basis of lipoarabinomannan to induce secretion of tumor necrosis factor. Infection and Immunity 60:1249–1253
    [Google Scholar]
  8. Chujor C. S. N., Kuhn B., Schwerer B., Bernheimer H., Levis W. R., Bevec D. 1992; Specific inhibition of mRNA accumulation for lymphokines in human T cell line Jurkat by mycobacterial lipoarabinomannan antigen. Clinical and Experimental Immunology 87:398–403
    [Google Scholar]
  9. Daffé M., Brennan P. J., Mcneill M. 1990; Predominant structural features of the cell wall arabinogalactan of Mycobacterium tuberculosis as revealed through characterization of oligoglycosyl alditol fragments by gas chromatography/mass spectrometry and by 1H and 13C NMR analyses. Journal of Biological Chemistry 265:6734–6743
    [Google Scholar]
  10. Dubois M., Gilles K. A., Hamilton J. K., Rebers P. A., Smith F. 1966; Colorimetric method for determination of sugars and related substances. Analytical Chemistry 28:350–356
    [Google Scholar]
  11. Gaylord H., Brennan P. J., Young D. B., Buchanan T. M. 1987; Most Mycobacterium leprae carbohydrate-reactive monoclonal antibodies are directed to lipoarabinomannan. Infection and Immunity 55:2860–2863
    [Google Scholar]
  12. Gerwig G. J., Kamerling J. P., Vliegenthart J. F. G. 1978; Determination of the d and l natural configuration of monosaccharides by high-resolution capillary g.l.c. Carbohydrate Research 62:349–357
    [Google Scholar]
  13. Hunter S. W., Brennan P. J. 1990; Evidence for the presence of a phosphatidylinositol anchor on the lipoarabinomannan and lipomannan of Mycobacterium tuberculosis. Journal of Biological Chemistry 265:9272–9279
    [Google Scholar]
  14. Hunter S. W., Gaylord H., Brennan P. J. 1986; Structure and antigenicity of the phosphorylated lipopolysaccharide antigens from the leprosy and tubercle bacilli. Journal of Biological Chemistry 261:12345–12351
    [Google Scholar]
  15. Kaplan G., Gandhi R. R., Weinstein D. E., Levis W. R., Patarroyo M. E., Brennan P. J., Cohn Z. A. 1987; Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro. Journal of Immunology 138:3028–3034
    [Google Scholar]
  16. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature; London: 227680–685
    [Google Scholar]
  17. Levis W. R., Meeker H. C., Schuller-Levis G., Sersen E., Brennan P. J., Fried P. 1987; Mycobacterial carbohydrate antigens for serological testing of patients with leprosy. Journal of Infectious Diseases 156:763–769
    [Google Scholar]
  18. Lipkind G. M., Shashkov A. S., Knirel Y. A., Vinogradov E. V., Kochetkov N. K. 1988; A computer-assisted structural analysis of regular polysaccharides on the basis of 13C-N.M.R. data. Carbohydrate Research 175:59–75
    [Google Scholar]
  19. Minnikin D. E., Alshamaony L., Goodfellow M. 1975; Differentiation of Mycobacterium, Nocardia and related taxa by thin layer chromatographic analysis of whole cell methanolysates. Journal of General Microbiology 88:200–204
    [Google Scholar]
  20. Misaki A., Azuma I., Yamamura Y. 1977; Structural and immunochemical studies on d-arabino-d-mannans and d-mannans of Mycobacterium tuberculosis and other Mycobacterium species. Journal of Biochemistry 82:1759–1770
    [Google Scholar]
  21. Molloy A., Gaudernack G., Levis W. R., Cohn Z. A., Kaplan G. 1990; Suppression of T-cell proliferation by Mycobacterium leprae and its products: the role of lipopolysaccharide. Proceedings of the National Academy of Sciences of the United States of America 87:973–977
    [Google Scholar]
  22. Moreno C., Mehlert A., Lamb J. 1988; The inhibitory effects of mycobacterial lipoarabinomannan and polysaccharides upon polyclonal and monoclonal human T cell proliferation. Clinical and Experimental Immunology 74:206–210
    [Google Scholar]
  23. Moreno C., Taverne J., Mehlert A., Bate C. A. W., Brealey R. J., Meager A., Rook G. A. W., Playfair J. H. L. 1989; Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumor necrosis factor from human and murine macrophages. Clinical and Experimental Immunology 76:240–245
    [Google Scholar]
  24. O’farrel P. H. 1975; High resolution two-dimensional electrophoresis of proteins. Journal of Biological Chemistry 250:4007–4021
    [Google Scholar]
  25. Sibley L. D., Hunter S. W., Brennan P. J., Krahenbuhl J. L. 1988; Mycobacterial lipoarabinomannan inhibits gamma interferon-mediated activation of macrophages. Infection and Immunity 56:1232–1236
    [Google Scholar]
  26. Sibley L. D., Adams L. B., Krahenbuhl J. L. 1990; Inhibition of interferon-gamma-mediated activation in mouse macrophages treated with lipoarabinomannan. Clinical and Experimental Immunology 80:141–148
    [Google Scholar]
  27. Sugden E. A., Samagh B. S., Bundle D. R., Duncan J. R. 1987; Lipoarabinomannan and lipid-free arabinomannan antigens of Mycobacterium paratuberculosis. Infection and Immunity 55:762–770
    [Google Scholar]
  28. Tsai C. M., Frasch C. M. 1982; A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Analytical Biochemistry 119:115–119
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/00221287-139-11-2649
Loading
/content/journal/micro/10.1099/00221287-139-11-2649
Loading

Data & Media loading...

Most cited Most Cited RSS feed